|
MORC4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.644300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.293560E-01 |
| Normal-vs-Stage2 |
2.520200E-02 |
| Normal-vs-Stage3 |
2.778200E-03 |
| Normal-vs-Stage4 |
1.339420E-01 |
| Stage1-vs-Stage2 |
1.981810E-01 |
| Stage1-vs-Stage3 |
5.442300E-02 |
| Stage1-vs-Stage4 |
5.001000E-01 |
| Stage2-vs-Stage3 |
7.751800E-01 |
| Stage2-vs-Stage4 |
6.610600E-01 |
| Stage3-vs-Stage4 |
4.420800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.604000E-03 |
| Normal-vs-AfricanAmerican |
3.939700E-03 |
| Normal-vs-Asian |
5.881800E-01 |
| Caucasian-vs-AfricanAmerican |
1.622170E-01 |
| Caucasian-vs-Asian |
9.415200E-01 |
| AfricanAmerican-vs-Asian |
4.900200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.159900E-03 |
| Normal-vs-Female |
5.932300E-02 |
| Male-vs-Female |
3.953400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.517000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.807800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.784300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.51800000020219E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.918820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.016200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.700330E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.222600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.919400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.801900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.563900E-02 |
| Normal-vs-Grade 2 |
8.921800E-02 |
| Normal-vs-Grade 3 |
5.582200E-04 |
| Normal-vs-Grade 4 |
9.997900E-02 |
| Grade 1-vs-Grade 2 |
7.163400E-01 |
| Grade 1-vs-Grade 3 |
6.109800E-01 |
| Grade 1-vs-Grade 4 |
8.948000E-01 |
| Grade 2-vs-Grade 3 |
6.144100E-02 |
| Grade 2-vs-Grade 4 |
4.492600E-01 |
| Grade 3-vs-Grade 4 |
6.841200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.923300E-03 |
| Normal-vs-ccB subtype |
5.649800E-01 |
| ccA subtype-vs-ccB subtype |
1.526580E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.355600E-02 |
| Normal-vs-N1 |
6.057800E-01 |
| N0-vs-N1 |
3.298800E-01 |
|
|
